Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT06853184

Study Evaluating the Efficacy and Safety of Artesunate

Led by Amivas Inc. · Updated on 2025-10-20

90

Participants Needed

2

Research Sites

152 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study is a randomized, open-label, active comparator-controlled, dose-ranging trial of the efficacy and safety of IV artesunate in combination with IV GCV or oral VGCV and SOC treatment compared to GCV or VGCV monotherapy and SOC treatment in SOT recipients with clinically significant CMV infection.

CONDITIONS

Official Title

Study Evaluating the Efficacy and Safety of Artesunate

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Be at least 18 years of age
  • Recipient of a solid organ transplant (kidney, lung, heart, or liver)
  • Have a documented CMV infection
  • Have CMV DNAemia
  • Require IV GCV or oral VGCV
  • Be washed out from any anti-CMV antiviral drugs
  • Have all the following results as part of screening laboratory assessments
  • Have life expectancy of 63 12 weeks
  • Be willing and have an understanding and ability to fully comply with the study
  • If female use birth control
Not Eligible

You will not qualify if you...

  • Have taken IV GCV or oral VGC daily for >8 days
  • Have refractory CMV infection or disease
  • Have CMV antiviral drug resistance
  • Have a known hypersensitivity to artesunate, GCV, or VGCV
  • Pregnant (or expecting to conceive) or nursing
  • Have severe liver disease
  • Require ongoing treatment with or an anticipated need for treatment with drugs with known interactions with artesunate or GCV
  • Taking any another investigational drug with anti-CMV activity

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Westmead Hospital

Westmead, Australia

Actively Recruiting

2

Princess Alexandra Hospital

Woolloongabba, Australia

Actively Recruiting

Loading map...

Research Team

L

Lisa Read

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here